Drug intelligence / Profile preview

Cetrimonium

Development stage: Unknown
Lead developer: Daniels
Modality: Recombinant Proteins and Enzymes, Small Molecules
Administration: Topical

Overview

Cetrimonium is a quaternary ammonium compound primarily used as a topical antiseptic and disinfectant. It acts as a surfactant and is effective against bacteria and fungi. Cetrimonium salts (such as cetrimonium chloride and cetrimonium bromide) are widely used in dermatological preparations for wound cleansing, seborrhoeic dermatitis treatment, and in cosmetic products like hair conditioners due to their ability to neutralize static electricity on hair. The mechanism of action involves disruption of microbial cell membranes through its surfactant properties[1][2][7][8].

Brand names: Xylonor
Other names: cetyltrimethylammoniumcetrimonium chloridecetrimonium bromideCTACCTAB

Beyond the preview

Go deeper on Cetrimonium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cetrimonium.

Explore the full profile